Unveiling the Pharmacological Potential of a Pyrazole–Benzodioxole Hybrid Computational Analysis, ADMET Screening, and Molecular Docking Against ABL Tyrosine Kinase

Documenti analoghi

• Novel Coumarin‐Pyrazole‐Thiazoles Hybrids: Synthesis, Anticancer Activity, Molecular Docking and In Silico ADMET prediction Studies
  di: Ayat K. Alsolimani, et al.
  Pubblicazione: (2024)
• Therapeutic Potential of Morin in Alzheimer's Disease: An Integrated Network Pharmacology, Molecular Docking, ADMET, and Molecular Dynamics Study
  di: Bandral Sunil Kumar, et al.
  Pubblicazione: (2026)
• Synthesis, Biological Screening, and Molecular Docking of Hybrid Pyrazole Scaffolds for Antitubercular and Antimicrobial Activity
  di: Abhay Bavishi, et al.
  Pubblicazione: (2025)
• Discovery of a New Isatin Scaffold for BCR‐ABL Tyrosine Kinase Inhibitors Using a Comprehensive Computational Approach
  di: Larbi EL Mchichi, et al.
  Pubblicazione: (2024)
• Multistage Computational Evaluation of Bedaquiline Pyridyl Derivatives: Unveiling Anti‐Tubercular Potential Through QSAR, Molecular Docking, Molecular Dynamics, ADMET, and DFT Analysis
  di: Anguraj Moulishankar, et al.
  Pubblicazione: (2026)